Collagen and Fibronectin

Collagen and fibronectin are the primary structural components of the extracellular matrix (ECM) synthesized by dermal fibroblasts. Collagen, predominantly Type I and Type III, provides the skin with tensile strength and structural integrity, while fibronectin acts as a multi-domain adhesive glycoprotein that facilitates cell-matrix interactions and guides cell migration (Source: UniProt P02452; P02751). In healthy skin, these proteins are essential for maintaining tissue architecture and facilitating the complex stages of wound healing (Source: StatPearls, "Physiology, Fibroblasts"). However, their dysregulation is a hallmark of several pathological states; excessive accumulation leads to fibrotic conditions such as keloids and systemic sclerosis, whereas their degradation by matrix metalloproteinases (MMPs) and reduced synthesis are primary drivers of skin aging and chronic wounds (Source: PubMed, PMID: 24831376). Therapeutic strategies often involve modulating the production of these proteins, such as using retinoids to stimulate collagen synthesis for anti-aging or employing anti-fibrotic agents like pirfenidone to inhibit pathological ECM deposition (Source: PubChem CID 444795; CID 40632). Consequently, these proteins serve as critical targets for both regenerative medicine and the treatment of fibroproliferative disorders.

Other names

Dermal extracellular matrixECM proteinsType I CollagenFibronectin 1

Stimulation of protein synthesis through nuclear receptor activation or inhibition of myofibroblast-mediated deposition.